Related Experiment Videos
[Spiramycin during infectious flare ups in chronic bronchitides patients evolution of blood and secretory
Le Poumon Et Le Coeur
|January 1, 1977
Abstract:
Thirty patients with chronic bronchitis were treated by spiramycin during bouts of surinfection. Seventy per cent of positive results were obtained. Checking the level of seral immunoglobulins and those of secretory IgA was not enough to judge the evolution.
Insights
Spiramycin treatment showed a 70% success rate in chronic bronchitis patients during infections. However, monitoring immunoglobulin levels alone was insufficient for tracking treatment effectiveness.
Area of Science:
- Respiratory Medicine
- Infectious Diseases
- Pharmacology
Background:
- Chronic bronchitis is a persistent respiratory condition often complicated by bacterial infections.
- Antibiotic therapy is crucial for managing infectious exacerbations in chronic bronchitis.
Purpose of the Study:
- To evaluate the efficacy of spiramycin in treating infectious bouts of chronic bronchitis.
- To assess the utility of immunoglobulin levels in monitoring treatment response.
Main Methods:
- A study involving thirty patients diagnosed with chronic bronchitis.
- Treatment administered: spiramycin during episodes of infection (surinfection).
- Monitoring of seral immunoglobulins and secretory IgA levels.
Main Results:
- Spiramycin yielded positive results in 70% of treated cases.
- Changes in seral immunoglobulin and secretory IgA levels did not reliably indicate treatment progress.
Conclusions:
- Spiramycin demonstrates considerable efficacy in managing infectious complications of chronic bronchitis.
- Immunological markers like immunoglobulins and IgA are not adequate for assessing treatment outcomes in this context.